Engineering recombinant reoviruses with tandem repeats and a tetravirus 2A-like element for exogenous polypeptide expression

Aleksander A. Demidenko, Joseph Blattman, Negin N. Blattman, Philip D. Greenberg, Max L. Nibert

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We tested a strategy for engineering recombinant mammalian reoviruses (rMRVs) to express exogenous polypeptides. One important feature is that these rMRVs are designed to propagate autonomously and can therefore be tested in animals as potential vaccine vectors. The strategy has been applied so far to three of the 10 MRV genome segments: S3, M1, and L1. To engineer the modified segments, a 5' or 3' region of the essential, long ORF in each was duplicated, and then exogenous sequences were inserted between the repeats. The inner repeat and exogenous insert were positioned in frame with the native protein-encoding sequences but were separated from them by an in-frame '2A-like' sequence element that specifies a cotranslational 'stop/continue' event releasing the exogenous polypeptide from the essential MRV protein. This design preserves a terminal region of the MRV genome segment with essential activities in RNA packaging, assortment, replication, transcription, and/or translation and alters the encoded MRV protein to a limited degree. Recovery of rMRVs with longer inserts was made more efficient by wobble-mutagenizing both the inner repeat and the exogenous insert, which possibly helped via respective reductions in homologous recombination and RNA structure. Immunogenicity of a 300-aa portion of the simian immunodeficiency virus Gag protein expressed in mice by an L1-modified rMRV was confirmed by detection of Gag-specific T-cell responses. The engineering strategy was further used formapping the minimal 5'-terminal region essential to MRV genome segment S3.

Original languageEnglish (US)
JournalProceedings of the National Academy of Sciences of the United States of America
Volume110
Issue number20
DOIs
StatePublished - May 14 2013

Fingerprint

Tandem Repeat Sequences
Genome
Peptides
RNA
gag Gene Products
Simian Immunodeficiency Virus
Proteins
Homologous Recombination
Product Packaging
Open Reading Frames
Vaccines
T-Lymphocytes

Keywords

  • DsRNA virus
  • Orthoreovirus
  • Reoviridae
  • Viral vector

ASJC Scopus subject areas

  • General

Cite this

Engineering recombinant reoviruses with tandem repeats and a tetravirus 2A-like element for exogenous polypeptide expression. / Demidenko, Aleksander A.; Blattman, Joseph; Blattman, Negin N.; Greenberg, Philip D.; Nibert, Max L.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, No. 20, 14.05.2013.

Research output: Contribution to journalArticle

@article{b81a9e2b948a443780048def619fd9c3,
title = "Engineering recombinant reoviruses with tandem repeats and a tetravirus 2A-like element for exogenous polypeptide expression",
abstract = "We tested a strategy for engineering recombinant mammalian reoviruses (rMRVs) to express exogenous polypeptides. One important feature is that these rMRVs are designed to propagate autonomously and can therefore be tested in animals as potential vaccine vectors. The strategy has been applied so far to three of the 10 MRV genome segments: S3, M1, and L1. To engineer the modified segments, a 5' or 3' region of the essential, long ORF in each was duplicated, and then exogenous sequences were inserted between the repeats. The inner repeat and exogenous insert were positioned in frame with the native protein-encoding sequences but were separated from them by an in-frame '2A-like' sequence element that specifies a cotranslational 'stop/continue' event releasing the exogenous polypeptide from the essential MRV protein. This design preserves a terminal region of the MRV genome segment with essential activities in RNA packaging, assortment, replication, transcription, and/or translation and alters the encoded MRV protein to a limited degree. Recovery of rMRVs with longer inserts was made more efficient by wobble-mutagenizing both the inner repeat and the exogenous insert, which possibly helped via respective reductions in homologous recombination and RNA structure. Immunogenicity of a 300-aa portion of the simian immunodeficiency virus Gag protein expressed in mice by an L1-modified rMRV was confirmed by detection of Gag-specific T-cell responses. The engineering strategy was further used formapping the minimal 5'-terminal region essential to MRV genome segment S3.",
keywords = "DsRNA virus, Orthoreovirus, Reoviridae, Viral vector",
author = "Demidenko, {Aleksander A.} and Joseph Blattman and Blattman, {Negin N.} and Greenberg, {Philip D.} and Nibert, {Max L.}",
year = "2013",
month = "5",
day = "14",
doi = "10.1073/pnas.1220107110",
language = "English (US)",
volume = "110",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "20",

}

TY - JOUR

T1 - Engineering recombinant reoviruses with tandem repeats and a tetravirus 2A-like element for exogenous polypeptide expression

AU - Demidenko, Aleksander A.

AU - Blattman, Joseph

AU - Blattman, Negin N.

AU - Greenberg, Philip D.

AU - Nibert, Max L.

PY - 2013/5/14

Y1 - 2013/5/14

N2 - We tested a strategy for engineering recombinant mammalian reoviruses (rMRVs) to express exogenous polypeptides. One important feature is that these rMRVs are designed to propagate autonomously and can therefore be tested in animals as potential vaccine vectors. The strategy has been applied so far to three of the 10 MRV genome segments: S3, M1, and L1. To engineer the modified segments, a 5' or 3' region of the essential, long ORF in each was duplicated, and then exogenous sequences were inserted between the repeats. The inner repeat and exogenous insert were positioned in frame with the native protein-encoding sequences but were separated from them by an in-frame '2A-like' sequence element that specifies a cotranslational 'stop/continue' event releasing the exogenous polypeptide from the essential MRV protein. This design preserves a terminal region of the MRV genome segment with essential activities in RNA packaging, assortment, replication, transcription, and/or translation and alters the encoded MRV protein to a limited degree. Recovery of rMRVs with longer inserts was made more efficient by wobble-mutagenizing both the inner repeat and the exogenous insert, which possibly helped via respective reductions in homologous recombination and RNA structure. Immunogenicity of a 300-aa portion of the simian immunodeficiency virus Gag protein expressed in mice by an L1-modified rMRV was confirmed by detection of Gag-specific T-cell responses. The engineering strategy was further used formapping the minimal 5'-terminal region essential to MRV genome segment S3.

AB - We tested a strategy for engineering recombinant mammalian reoviruses (rMRVs) to express exogenous polypeptides. One important feature is that these rMRVs are designed to propagate autonomously and can therefore be tested in animals as potential vaccine vectors. The strategy has been applied so far to three of the 10 MRV genome segments: S3, M1, and L1. To engineer the modified segments, a 5' or 3' region of the essential, long ORF in each was duplicated, and then exogenous sequences were inserted between the repeats. The inner repeat and exogenous insert were positioned in frame with the native protein-encoding sequences but were separated from them by an in-frame '2A-like' sequence element that specifies a cotranslational 'stop/continue' event releasing the exogenous polypeptide from the essential MRV protein. This design preserves a terminal region of the MRV genome segment with essential activities in RNA packaging, assortment, replication, transcription, and/or translation and alters the encoded MRV protein to a limited degree. Recovery of rMRVs with longer inserts was made more efficient by wobble-mutagenizing both the inner repeat and the exogenous insert, which possibly helped via respective reductions in homologous recombination and RNA structure. Immunogenicity of a 300-aa portion of the simian immunodeficiency virus Gag protein expressed in mice by an L1-modified rMRV was confirmed by detection of Gag-specific T-cell responses. The engineering strategy was further used formapping the minimal 5'-terminal region essential to MRV genome segment S3.

KW - DsRNA virus

KW - Orthoreovirus

KW - Reoviridae

KW - Viral vector

UR - http://www.scopus.com/inward/record.url?scp=84877842499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877842499&partnerID=8YFLogxK

U2 - 10.1073/pnas.1220107110

DO - 10.1073/pnas.1220107110

M3 - Article

C2 - 23630248

AN - SCOPUS:84877842499

VL - 110

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 20

ER -